what are the dangers of tirzepatide Systemic effects dually activating GLP-1 and GIP Tirzepatide Side Effects: Risks, Safety,

Thats a significant achievementand its absolutely within reach

58 Ophthalmic complications After two years of low-dose semaglutide 1 mg once weekly in people with type 2 diabetes, there was a 76% increased risk of worsening retinopathy compared with placebo, although the absolute event rate was low (3.0% with semaglutide vs 1.8% with placebo)

Benefits may vary A number of users did not notice clear changes despite continued use

Wegovy pill may be prescribed for adults with: BMI of 30+ (obesity) BMI of 27+ with at least one weight-related condition Eligibility is determined by a licensed healthcare provider after medical evaluation